|
|
||||||||
The FASEB Journal, Vol 1, 289-297, Copyright © 1987 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
RB Clark, J Friedman, JA Johnson and MW Kunkel
Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston 77225.
Treatment with low physiological concentrations of epinephrine (5-50 nM) rapidly desensitizes beta-adrenergic stimulation of cAMP formation in S49 wild-type (WT) lymphoma cells. Previous attempts to detect this early phase of desensitization in cell-free assays of adenylate cyclase (EC 4.6.1.1) after intact cell treatment were unsuccessful. We have now found that reducing the Mg2+ concentrations in the adenylate cyclase assays to less than 1.0 mM unmasked this rapid phase of desensitization of the WT cells, and that high Mg2+ concentrations (5-10 mM) largely obscured the desensitization. Submillimolar Mg2+ conditions also revealed a two- to threefold decrease in the affinity of epinephrine binding to the beta-adrenergic receptor after desensitization with 20 nM epinephrine. Detection of 4 beta-phorbol 12-myristate 13-acetate (PMA) desensitization of the WT beta-adrenergic receptor was also dependent on low Mg2+ as measured either by the decrease in epinephrine stimulation of adenylate cyclase or by the reduction in the affinity of epinephrine binding. Unexpectedly, when cyc- cells were pretreated with 50 nM epinephrine, the beta-adrenergic stimulation of reconstituted adenylate cyclase was not desensitized. The characteristics of the Mg2+ effect on epinephrine- and PMA-induced desensitizations suggest a similar mechanism of action with the most likely events being phosphorylations of the beta-adrenergic receptors. Our data indicate that cAMP-dependent protein kinase (EC 2.7.1.37) may play a role in the desensitization caused by low epinephrine concentrations inasmuch as this phase of desensitization did not occur in the cyc-. For the PMA- induced desensitization, the phosphorylation may be mediated by protein kinase C (EC 2.7.1.37).
This article has been cited by other articles:
![]() |
R. B. Penn, J.-L. Parent, A. N. Pronin, R. A. Panettieri Jr., and J. L. Benovic Pharmacological Inhibition of Protein Kinases in Intact Cells: Antagonism of Beta Adrenergic Receptor Ligand Binding by H-89 Reveals Limitations of Usefulness J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 428 - 437. [Abstract] [Full Text] |
||||
![]() |
K. Schulz, S. Danner, P. Bauer, S. Schroder, and M. J. Lohse Expression of Phosducin in a Phosducin-negative Cell Line Reveals Functions of a Gbeta gamma -binding Protein J. Biol. Chem., September 13, 1996; 271(37): 22546 - 22551. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Post, O. Aguila-Buhain, and P. A. Insel A Key Role for Protein Kinase A in Homologous Desensitization of the beta(2)-Adrenergic Receptor Pathway in S49 Lymphoma Cells J. Biol. Chem., January 12, 1996; 271(2): 895 - 900. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |